Page last updated: 2024-10-24

chlorambucil and BLV Infections

chlorambucil has been researched along with BLV Infections in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naito, K2
Kubo, K1
Akao, Y1
Hiraiwa, A1
Naoe, T1
Yamada, K2
Ogawa, T1

Other Studies

2 other studies available for chlorambucil and BLV Infections

ArticleYear
[Clinical trial of bestrabucil (KM 2210) in hematopoietic malignancies].
    Gan no rinsho. Japan journal of cancer clinics, 1986, Volume: 32, Issue:11

    Topics: Aged; Chlorambucil; Deltaretrovirus Infections; Estradiol; Female; Humans; Lymphoma; Male; Middle Ag

1986
[A case of adult T cell leukemia treated with a new chemotherapeutic agent, KM2210].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:1

    Topics: Antigens, Viral; Chlorambucil; Deltaretrovirus Infections; Estradiol; HIV Antigens; Humans; Lymphocy

1987